Skip to main content
Top
Published in: Drug Safety 1/2018

01-01-2018 | Meeting Report

The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance

Authors: Vicki Osborne, Saad A. W. Shakir

Published in: Drug Safety | Issue 1/2018

Login to get access

Excerpt

Since its inception in 2001, the Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance has aimed to keep up to date with continuous developments in the field of signal detection, and this ninth conference in June 2017 was no exception. The proceedings from the first conference have been published previously and covered topics such as screening algorithms [1], data mining [2] and causal association in pharmacovigilance [3]. Many conferences run annually and risk a lack of progress from year to year, whereas a biennial format ensures progress has always been made since the previous meeting. Expert speakers from around the world participated this year, providing relevant updates for anyone working in the signal detection field in addition to a global perspective on pharmacovigilance practices. A pre-conference tutorial covered the importance of signal detection in pharmacovigilance, an introduction to disproportionality analysis and the responsibilities of marketing authorisation holders (MAHs). The full meeting programme is available on the official conference website: http://​www.​dsru.​org/​courses/​international-conferences/​. …
Literature
1.
go back to reference Szarfman A, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf. 2002;25(6):381–92.CrossRefPubMed Szarfman A, Machado SG, O’Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA’s spontaneous reports database. Drug Saf. 2002;25(6):381–92.CrossRefPubMed
2.
go back to reference Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf. 2002;25(6):393–7.CrossRefPubMed Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf. 2002;25(6):393–7.CrossRefPubMed
3.
go back to reference Shakir SAW, Layton D. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria. Drug Saf. 2002;25(6):467–71.CrossRefPubMed Shakir SAW, Layton D. Causal association in pharmacovigilance and pharmacoepidemiology: thoughts on the application of the Austin Bradford-Hill criteria. Drug Saf. 2002;25(6):467–71.CrossRefPubMed
4.
go back to reference Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18(6):427–36.CrossRefPubMed Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18(6):427–36.CrossRefPubMed
5.
go back to reference Chandler RE, Juhlin K, Fransson J, Caster O, Edwards IR, Norén GN. current safety concerns with human papillomavirus vaccine: a cluster analysis of reports in VigiBase(®). Drug Saf. 2017;40(1):81–90.CrossRefPubMed Chandler RE, Juhlin K, Fransson J, Caster O, Edwards IR, Norén GN. current safety concerns with human papillomavirus vaccine: a cluster analysis of reports in VigiBase(®). Drug Saf. 2017;40(1):81–90.CrossRefPubMed
7.
go back to reference Wisniewski AFZ, Bate A, Bousquet C, Brueckner A, Candore G, Juhlin K, et al. Good signal detection practices: evidence from IMI PROTECT. Drug Saf. 2016;39(6):469–90.CrossRefPubMedPubMedCentral Wisniewski AFZ, Bate A, Bousquet C, Brueckner A, Candore G, Juhlin K, et al. Good signal detection practices: evidence from IMI PROTECT. Drug Saf. 2016;39(6):469–90.CrossRefPubMedPubMedCentral
9.
go back to reference Lerch M, Nowicki P, Manlik K, Wirsching G. Statistical signal detection as a routine pharmacovigilance practice: effects of periodicity and resignalling criteria on quality and workload. Drug Saf. 2015;38(12):1219–31.CrossRefPubMedPubMedCentral Lerch M, Nowicki P, Manlik K, Wirsching G. Statistical signal detection as a routine pharmacovigilance practice: effects of periodicity and resignalling criteria on quality and workload. Drug Saf. 2015;38(12):1219–31.CrossRefPubMedPubMedCentral
10.
go back to reference Caster O, Juhlin K, Watson S, Norén GN. Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank. Drug Saf. 2014;37(8):617–28.CrossRefPubMedPubMedCentral Caster O, Juhlin K, Watson S, Norén GN. Improved statistical signal detection in pharmacovigilance by combining multiple strength-of-evidence aspects in vigiRank. Drug Saf. 2014;37(8):617–28.CrossRefPubMedPubMedCentral
11.
go back to reference Caster O, Sander L, Juhlin K, Watson S, Norén GN. vigiRank improves realworld signal detection performance: prospective results from international pharmacovigilance. Drug Saf. 2015;38(10):975–6. Caster O, Sander L, Juhlin K, Watson S, Norén GN. vigiRank improves realworld signal detection performance: prospective results from international pharmacovigilance. Drug Saf. 2015;38(10):975–6.
12.
go back to reference Seabroke S, Wise L, Waller P. Development of a novel regulatory pharmacovigilance prioritisation system: an evaluation of its performance at the UK medicines and healthcare products regulatory agency. Drug Saf. 2013;36(10):1025–32.CrossRefPubMed Seabroke S, Wise L, Waller P. Development of a novel regulatory pharmacovigilance prioritisation system: an evaluation of its performance at the UK medicines and healthcare products regulatory agency. Drug Saf. 2013;36(10):1025–32.CrossRefPubMed
13.
go back to reference Norén GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Min Knowl Discov. 2010;20(3):361–87.CrossRef Norén GN, Hopstadius J, Bate A, Star K, Edwards IR. Temporal pattern discovery in longitudinal electronic patient records. Data Min Knowl Discov. 2010;20(3):361–87.CrossRef
14.
go back to reference Hauben M, Whalen E, Bate A. 16th ISoP Annual Meeting “‘Pharmacovigilance for Safer Tomorrow’” Agra, India 16–19 October, 2016: time series disturbance detection for hypothesis-free signal detection in longitudinal observational databases. Drug Saf. 2016;39(10):1015. Hauben M, Whalen E, Bate A. 16th ISoP Annual Meeting “‘Pharmacovigilance for Safer Tomorrow’” Agra, India 16–19 October, 2016: time series disturbance detection for hypothesis-free signal detection in longitudinal observational databases. Drug Saf. 2016;39(10):1015.
15.
go back to reference Kulldorff M, Dashevsky I, Avery TR, Chan AK, Davis RL, Graham D, et al. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013;22(5):517–23.CrossRefPubMed Kulldorff M, Dashevsky I, Avery TR, Chan AK, Davis RL, Graham D, et al. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013;22(5):517–23.CrossRefPubMed
16.
go back to reference Choi E, Bahadori MT, Schuetz A, Stewart WF, Sun J. Doctor AI: predicting clinical events via recurrent neural networks. JMLR Workshop Conf Proc. 2016;56:301–18.PubMedPubMedCentral Choi E, Bahadori MT, Schuetz A, Stewart WF, Sun J. Doctor AI: predicting clinical events via recurrent neural networks. JMLR Workshop Conf Proc. 2016;56:301–18.PubMedPubMedCentral
Metadata
Title
The 9th Biennial Conference on Signal Detection and Interpretation in Pharmacovigilance
Authors
Vicki Osborne
Saad A. W. Shakir
Publication date
01-01-2018
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 1/2018
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-017-0587-1

Other articles of this Issue 1/2018

Drug Safety 1/2018 Go to the issue